i-FACTOR Bone Graft

About Cerapedics

Cerapedics is a privately held medical device company founded in 2005, headquartered in Westminster, Colorado, USA. It has established a commercial-stage presence in the orthopedic bone graft market with its proprietary P-15 peptide technology platform, which is designed to attract and activate osteogenic cells to accelerate bone formation. The company's portfolio includes two FDA-approved products, i-FACTOR for cervical fusion and the recently approved PearlMatrix for lumbar fusion, both supported by rigorous PMA clinical data. Cerapedics operates in a large and growing spinal fusion market, competing on the strength of its clinical evidence and differentiated mechanism of action.

Therapeutic Areas